The authors quantified how treatment effects differ between older and younger patients in oncology registration trials . The primary outcome was differential treatment effect by age for progression-free survival and overall survival . Only 7% of end points showed a statistically significant interaction between outcome and age group . There were no changes in the proportion of patients aged 65 years or older over time .